Tenet Healthcare (THC) Misses Q2 EPS by 2c, Miss on Revenues; Offers FY17 EPS/Revenue Guidance Below Consensus

Go back to Tenet Healthcare (THC) Misses Q2 EPS by 2c, Miss on Revenues; Offers FY17 EPS/Revenue Guidance Below Consensus

Tenet Healthcare (THC) PT Lowered to $24 at Jefferies

August 8, 2017 8:21 AM EDT

Jefferies lowered its price target on Tenet Healthcare (NYSE: THC) to $24.00 (from $26.00) while maintaining a Buy rating. While THC's Q2 results came in slightly below consensus, analyst Brian Tanquilut views the revenue and EBITDA shortfalls as modest relative to expectations baked into the... More